Commercially available antibodies used in this study are: ROR1, UHRF1 (#4102, #12387, Cell Signaling, Danvers MA), ROR1 (#AF2000, R&D Systems, Minneapolis MN), UHRF1 (#612264, BD Biosciences, San Jose CA), goat IgG serum (#005-000-003, Jackson ImmunoResearch, West Grove PA), mouse IgG serum (#sc-2025, Santa Cruz Biotechnology, Santa Cruz CA), actin, GAPDH, SP1 (#AM4300, #07-645, Millipore, Burlington MA), V5 (#46-0705, Invitrogen, Carlsbad CA), and ubiquitin (#A-104, Boston Biochem, Cambridge MA). The ROR1 antibody has been validated by the manufacturer and we have also tested this antibody in multiple cell lines to correlate immunoblot data with cell lines known to express or not express ROR1 at the transcript level (Supplementary Figure 5 ). Commercially available inhibitors used in this study are: Velcade (Bortezomib), dasatinib (SelleckChem, Houston TX), anisomycin (Cayman Chemical, Ann Arbor MI), naphthazarin, thymoquinone (Sigma, St. Louis MO), and flavopiridol (LC Laboratories, Woburn MA).
Mouse igg serum
Manufactured by Santa Cruz Biotechnology
Mouse IgG serum is a laboratory reagent that contains immunoglobulin G (IgG) antibodies purified from the serum of mice. It is commonly used as a control or reference material in various immunological assays and techniques.
Automatically generated - may contain errors
Lab products found in correlation
Gapdh, by Merck Group (2 mentions)
Ubiquitin, by R&D Systems (2 mentions)
Anisomycin, by Cayman Chemical (2 mentions)
Naphthazarin, by Merck Group (2 mentions)
Dasatinib, by Selleck Chemicals (2 mentions)
Uhrf1, by Cell Signaling Technology (2 mentions)
Uhrf1, by BD (2 mentions)
Goat igg serum, by Jackson ImmunoResearch (2 mentions)
Thymoquinone, by Merck Group (2 mentions)
Flavopiridol, by LC Laboratories (2 mentions)
2 protocols using mouse igg serum
1
Antibody Validation and Inhibitor Usage
2
Antibody Validation and Inhibitor Usage
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Commercially available antibodies used in this study are: ROR1, UHRF1 (#4102, #12387, Cell Signaling, Danvers MA), ROR1 (#AF2000, R&D Systems, Minneapolis MN), UHRF1 (#612264, BD Biosciences, San Jose CA), goat IgG serum (#005-000-003, Jackson ImmunoResearch, West Grove PA), mouse IgG serum (#sc-2025, Santa Cruz Biotechnology, Santa Cruz CA), actin, GAPDH, SP1 (#AM4300, #07-645, Millipore, Burlington MA), V5 (#46-0705, Invitrogen, Carlsbad CA), and ubiquitin (#A-104, Boston Biochem, Cambridge MA). The ROR1 antibody has been validated by the manufacturer and we have also tested this antibody in multiple cell lines to correlate immunoblot data with cell lines known to express or not express ROR1 at the transcript level (Supplementary Figure 5 ). Commercially available inhibitors used in this study are: Velcade (Bortezomib), dasatinib (SelleckChem, Houston TX), anisomycin (Cayman Chemical, Ann Arbor MI), naphthazarin, thymoquinone (Sigma, St. Louis MO), and flavopiridol (LC Laboratories, Woburn MA).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!